from Reuters: Health News https://ift.tt/2MSObv5
Monday, 28 October 2019
AstraZeneca's combo drug for lung cancer succeeds in late-stage trial
AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a late-stage study, sending its shares up 2%.
from Reuters: Health News https://ift.tt/2MSObv5
from Reuters: Health News https://ift.tt/2MSObv5
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment